pfizer glp-1 drug Danuglipron: An Oral GLP-1R Agonist Competing with Peptide Injectables for Diabetes and Obesity Why GLP-1 Weight-Loss Drugs Are
Description
Among the marketed large molecule injectable GLP-1 agonists, semaglutide, apart from weight-loss, is being studied for kidney disease and tirzepatide (a dual GLP-1 and GIP receptor agonist) is being evaluated for sleep apnea in Ph 3 clinical trials
More ...
The Gila monster (Heloderma suspectum), a unique lizard known for its binge-eating behavior, produces the hormone exenatide, the basis for diabetes medications such as Ozempic and Mounjaro
They might
In this Review, the authors discuss the potential effects of GLP-1 receptor agonists on the incidence, disease activity and progression of various forms of arthritis, as well as practical considerations for their use in this context.
#glp1 #diabetes #medication #T2DM | 28 comments on LinkedIn
